ArticleFrontiers in genetics2021

ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among

Jun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.